|Articles|March 4, 2009
Wavefront-guided retreatment after primary wavefront-guided LASIK in Myopes and Hyperopes
Wavefront-guided retreatment after primary wavefront-guided LASIK in Myopes and Hyperopes
Advertisement
Wavefront-guided retreatment after primary wavefront-guided LASIK in Myopes and Hyperopes: long-term follow-up, from the February 18 issue of the American Journal of Ophthalmology.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
From skepticism to clarity and focus: A family’s PRESBYOND experience
2
Patent granted to Kiora Pharmaceuticals' KIO-100 formulations
3
How Digital Workflow Boosted my Confidence and Elevated Premium Patient Rates in Cataract Surgery
4
Celltrion’s EYLEA-referencing biosimilar, EYDENZELT, receives Canadian approval
5











































